Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Orange, California and other locations
Dates
study started
estimated completion
Principal Investigator
by Shuichi Suzuki

Description

Summary

The purpose of this Registry is to assess the procedural success and clinical outcomes associated with various operator techniques for mechanical thrombectomy in large vessel occlusions (LVO).

Official Title

ASSIST Registry to Assess the Procedural Success and Clinical Outcomes Associated With Various Operator Techniques for Mechanical Thrombectomy in Large Vessel Occlusions (LVO).

Details

ASSIST is a prospective, global, consecutive enrollment Registry of anterior circulation acute ischemic stroke patients with an LVO who undergo treatment with one of the interventional techniques using Stryker Neurovascular devices for the first pass. The purpose of this Registry is to assess the procedural success and clinical outcomes associated with various operator techniques for mechanical thrombectomy in large vessel occlusions (LVO) in the anterior circulation. Data will be collected on the use of Stryker market-released neurovascular mechanical access and mechanical thrombectomy devices that are commercially available or that may be approved for commercial use during the conduct of the Registry. This Registry will also collect data, including time-to-treatment and quality of life measures, to allow for subset analyses.

Keywords

Ischemic Stroke Mechanical Thrombectomy SR Classic Direct Aspiration

Eligibility

You can join if…

Open to people ages 18 years and up

  • Subjects experiencing acute ischemic stroke (AIS) who are eligible for restoration of blood flow using Stryker Neurovascular market-released products in the neurovasculature to remove thrombus
  • Occlusion of intracranial anterior circulation vessel
  • Subject or subject's legally authorized representative (LAR) has signed the informed consent form prior to or within 48 hours post-procedure
  • Subject is willing to comply with the protocol follow-up requirements
  • Subject is treated using at least one of the defined techniques for the first pass in the neurovasculature to remove thrombus.

You CAN'T join if...

  • The subject is participating in another device trial or any other clinical trial where the study procedure or treatment might confound this study's endpoint.

Locations

  • UC Irvine accepting new patients
    Orange California 92868 United States
  • UCLA Medical Center accepting new patients
    Los Angeles California 90095 United States

Lead Scientist at UC Irvine

  • Shuichi Suzuki
    Clinical Professor, Neurosurgery. Authored (or co-authored) 16 research publications.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Stryker Neurovascular
ID
NCT03845491
Study Type
Observational [Patient Registry]
Last Updated